On February 19, 2025, BeyondSpring Inc. completed the first closing of an asset sale, transferring 1,730,454 Series A-1 Preferred Shares of SEED Therapeutics Inc. for $7,354,432.75, with total expected proceeds of approximately $35.4 million from the sale of 8,333,637 Shares. Additionally, on February 17, 2025, an amendment was made to transfer 230,400 additional Shares for $979,203.25.